More News

17 Feb 2021 Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis
16 Feb 2021 Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
16 Feb 2021 Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important Pediatric and Adult Deafness Segments
16 Feb 2021 Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
09 Feb 2021 Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial
05 Feb 2021 Imcyse Enters into Research Collaboration and License Agreement for its Imotope™ Technology with Pfizer in Rheumatoid Arthritis
03 Feb 2021 Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
02 Feb 2021 X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech
02 Feb 2021 Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
01 Feb 2021 Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure
01 Feb 2021 Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
25 Jan 2021 Evozyne and Takeda Announce Strategic Collaboration and License Agreement
21 Jan 2021 Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
20 Jan 2021 Turnstone Biologics Acquires Novel Cell Therapy Platform
18 Jan 2021 Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
15 Jan 2021 Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases
15 Jan 2021 Syntekabio Signs Joint Development Agreement with Hanmi Science
13 Jan 2021 Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
13 Jan 2021 EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
13 Jan 2021 Actinium and Astellas Announce Research Collaboration Focused on Novel Actinium-225 Based Targeted Radiotherapies
12 Jan 2021 La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe
12 Jan 2021 Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
11 Jan 2021 Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs
11 Jan 2021 Eligo Bioscience inks deal with GSK potentially worth up to $224 million
10 Jan 2021 Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up